NO20062389L - Fremgangsmate for spray-storkning ved anvendelse av en ekstruder for fremstilling av multipartikkulaere azitromycinmaterialer - Google Patents

Fremgangsmate for spray-storkning ved anvendelse av en ekstruder for fremstilling av multipartikkulaere azitromycinmaterialer

Info

Publication number: NO20062389L
Authority: NO; Norway
Prior art keywords: extruder; prepare; materials; azithromycin; spray solidification
Prior art date: 2003-12-04

Application number

NO20062389A

Other languages

English (en)

Norwegian (no)

Inventor

Scott Max Herbig

Julian Belknap Lo

Leah Elizabeth Appel

Marshall David Crew

Dwayne Thomas Friesen

David Keith Lyon

Scott Baldwin Mccray

Roderick Jack Ray

James Blair West

David Dixon Newbold

Steven Ross Lemott

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-12-04

Filing date

2006-05-24

Publication date

2006-06-16

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34652484&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20062389(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-05-24 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2006-06-16 Publication of NO20062389L publication Critical patent/NO20062389L/no

Links

MQTOSJVFKKJCRP-BICOPXKESA-N azithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)N(C)C[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 MQTOSJVFKKJCRP-BICOPXKESA-N 0.000 title abstract 3
229960004099 azithromycin Drugs 0.000 title abstract 2
238000000034 method Methods 0.000 title abstract 2
238000007711 solidification Methods 0.000 title abstract 2
239000000463 material Substances 0.000 title 1
230000008023 solidification Effects 0.000 title 1
239000007921 spray Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Glanulating (AREA)

NO20062389A 2003-12-04 2006-05-24 Fremgangsmate for spray-storkning ved anvendelse av en ekstruder for fremstilling av multipartikkulaere azitromycinmaterialer NO20062389L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US52724403P	2003-12-04	2003-12-04
PCT/IB2004/003839 WO2005053653A1 (en)	2003-12-04	2004-11-22	Spray-congeal process using an extruder for preparing multiparticulate azithromycin compositions containing preferably a poloxamer and a glyceride

Publications (1)

Publication Number	Publication Date
NO20062389L true NO20062389L (no)	2006-06-16

Family

ID=34652484

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20062389A NO20062389L (no)	2003-12-04	2006-05-24	Fremgangsmate for spray-storkning ved anvendelse av en ekstruder for fremstilling av multipartikkulaere azitromycinmaterialer

Country Status (15)

Country	Link
US (1)	US20050158391A1 (pt)
EP (1)	EP1701702A1 (pt)
JP (1)	JP2007513143A (pt)
KR (2)	KR20080064209A (pt)
CN (1)	CN1889931A (pt)
AR (1)	AR046468A1 (pt)
AU (1)	AU2004294813A1 (pt)
BR (1)	BRPI0416535A (pt)
CA (1)	CA2547773A1 (pt)
IL (1)	IL175745A0 (pt)
NO (1)	NO20062389L (pt)
RU (1)	RU2006119464A (pt)
TW (1)	TW200528138A (pt)
WO (1)	WO2005053653A1 (pt)
ZA (1)	ZA200604495B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2011039686A1 (en)	2009-09-30	2011-04-07	Pfizer Inc.	Latrepirdine oral sustained release dosage forms
WO2013090452A1 (en)	2011-12-12	2013-06-20	Orbis Biosciences, Inc.	Sustained release particle formulations
WO2013088274A1 (en)	2011-12-14	2013-06-20	Wockhardt Limited	Anhydrous amorphous azithromycin composition free of azithromycin dihydrate
JP6041823B2 (ja)	2013-03-16	2016-12-14	ファイザー・インク	トファシチニブの経口持続放出剤形
WO2019072877A1 (en)	2017-10-10	2019-04-18	Capsugel Belgium Nv	GETTING MULTIPARTICULAR COMPOSITIONS
CN109288798A (zh) *	2018-12-08	2019-02-01	海南医学院	一种阿奇霉素掩味微球的制备方法
WO2021014360A1 (en)	2019-07-23	2021-01-28	Pfizer Inc.	Oral modified release dosage forms
EP4057989A1 (en)	2019-11-14	2022-09-21	Pfizer Inc.	1-(((2s,3s,4s)-3-ethyl-4-fluoro-5-oxopyrrolidin-2-yl)methoxy)-7-methoxyisoquinoline-6-carboxamide combinations and oral dosage forms
US20230181463A1 (en) *	2020-05-15	2023-06-15	Massachusetts Institute Of Technology	Oleogel and oleopaste compositions and uses thereof

Family Cites Families (96)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6650A (en) *		1849-08-14		Edmund blunt
US3590A (en) *		1844-05-17		Rule or measure
US2955956A (en) *	1957-05-15	1960-10-11	Morton Salt Co	Process and apparatus for coating granules
US4086346A (en) *	1974-04-06	1978-04-25	Bayer Aktiengesellschaft	Preparation of melt-sprayed spherical phenacetin granules
US4092089A (en) *	1974-04-06	1978-05-30	Bayer Aktiengesellschaft	Apparatus for the preparation of melt-sprayed spherical phenacetin granules
US4053264A (en) *	1976-01-30	1977-10-11	United Technologies Corporation	Apparatus for making metal powder
US4293570A (en) *	1979-04-02	1981-10-06	Chimicasa Gmbh	Process for the preparation of sweetener containing product
YU43006B (en) *	1981-03-06	1989-02-28	Pliva Pharm & Chem Works	Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
US4474768A (en) *	1982-07-19	1984-10-02	Pfizer Inc.	N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
KR920006865B1 (ko) *	1984-05-18	1992-08-21	워싱톤 유니버시티 테크놀러지 어소우시에이츠 인코오퍼레이티드	입자나 액적을 피복하는 방법과 장치
US4874611A (en) *	1985-06-20	1989-10-17	The Dow Chemical Company	Microencapsulated ant bait
US5100592A (en) *	1986-03-12	1992-03-31	Washington University Technology Associated, Inc.	Method and apparatus for granulation and granulated product
US5019302A (en) *	1986-03-12	1991-05-28	Washington University Technology Associates, Inc.	Method for granulation
US5236734A (en) *	1987-04-20	1993-08-17	Fuisz Technologies Ltd.	Method of preparing a proteinaceous food product containing a melt spun oleaginous matrix
US5387431A (en) *	1991-10-25	1995-02-07	Fuisz Technologies Ltd.	Saccharide-based matrix
US5456932A (en) *	1987-04-20	1995-10-10	Fuisz Technologies Ltd.	Method of converting a feedstock to a shearform product and product thereof
MX12213A (es) *	1987-07-09	1993-05-01	Pfizer	Metodo de preparacion de dihidrato de azitromicina cristalino
WO1989002271A1 (en) *	1987-09-10	1989-03-23	Pfizer	Azithromycin and derivatives as antiprotozoal agents
DE3812567A1 (de) *	1988-04-15	1989-10-26	Basf Ag	Verfahren zur herstellung pharmazeutischer mischungen
US5064650A (en) *	1988-04-19	1991-11-12	Southwest Research Institute	Controlled-release salt sensitive capsule for oral use and adhesive system
US4931285A (en) *	1988-04-28	1990-06-05	Alza Corporation	Aqueous based pharmaceutical coating composition for dosage forms
US5160743A (en) *	1988-04-28	1992-11-03	Alza Corporation	Annealed composition for pharmaceutically acceptable drug
US5024842A (en) *	1988-04-28	1991-06-18	Alza Corporation	Annealed coats
US5047244A (en) *	1988-06-03	1991-09-10	Watson Laboratories, Inc.	Mucoadhesive carrier for delivery of therapeutical agent
US5084287A (en) *	1990-03-15	1992-01-28	Warner-Lambert Company	Pharmaceutically useful micropellets with a drug-coated core and controlled-release polymeric coat
US5213810A (en) *	1990-03-30	1993-05-25	American Cyanamid Company	Stable compositions for parenteral administration and method of making same
EP0452862B1 (en) *	1990-04-18	1995-07-19	Asahi Kasei Kogyo Kabushiki Kaisha	Spherical seed cores, spherical granules and process for production thereof
US5183690A (en) *	1990-06-25	1993-02-02	The United States Of America, As Represented By The Secretary Of Agriculture	Starch encapsulation of biologically active agents by a continuous process
GB9014646D0 (en) *	1990-07-02	1990-08-22	Courtaulds Coatings Holdings	Coating compositions
US5194262A (en) *	1990-10-22	1993-03-16	Revlon Consumer Products Corporation	Encapsulated antiperspirant salts and deodorant/antiperspirants
US5196199A (en) *	1990-12-14	1993-03-23	Fuisz Technologies Ltd.	Hydrophilic form of perfluoro compounds and method of manufacture
US5292657A (en) *	1990-12-31	1994-03-08	Pioneer Hi-Bred International, Inc.	Process for preparing rotary disc fatty acid microspheres of microorganisms
US5143662A (en) *	1991-02-12	1992-09-01	United States Surgical Corporation	Process for preparing particles of bioabsorbable polymer
US5405617A (en) *	1991-11-07	1995-04-11	Mcneil-Ppc, Inc.	Aliphatic or fatty acid esters as a solventless carrier for pharmaceuticals
GB9201857D0 (en) *	1992-01-29	1992-03-18	Smithkline Beecham Plc	Novel compound
JP3265680B2 (ja) *	1992-03-12	2002-03-11	大正製薬株式会社	経口製剤用組成物
DE4214272A1 (de) *	1992-05-04	1993-11-11	Nukem Gmbh	Verfahren und Vorrichtung zur Herstellung von Mikrokugeln
CA2095776C (en) *	1992-05-12	2007-07-10	Richard C. Fuisz	Rapidly dispersable compositions containing polydextrose
AU4316393A (en) *	1992-05-22	1993-12-30	Godecke Aktiengesellschaft	Process for preparing delayed-action medicinal compositions
US5518730A (en) *	1992-06-03	1996-05-21	Fuisz Technologies Ltd.	Biodegradable controlled release flash flow melt-spun delivery system
TW271400B (pt) *	1992-07-30	1996-03-01	Pfizer
US5348758A (en) *	1992-10-20	1994-09-20	Fuisz Technologies Ltd.	Controlled melting point matrix formed with admixtures of a shearform matrix material and an oleaginous material
US5380473A (en) *	1992-10-23	1995-01-10	Fuisz Technologies Ltd.	Process for making shearform matrix
GB9224855D0 (en) *	1992-11-27	1993-01-13	Smithkline Beecham Plc	Pharmaceutical compositions
US5569467A (en) *	1993-05-15	1996-10-29	Societe De Conseils De Recherches Et D'applications (S.C.R.A.S.)	Process for the preparation of microballs and microballs thus obtained
IL109770A0 (en) *	1993-05-29	1994-11-28	Smithkline Beecham Corp	Thermal infusion process for preparing controlled release solid dosage forms of medicaments for oral administration and controlled release solid dosage forms of medicaments prepared thereby
US5597416A (en) *	1993-10-07	1997-01-28	Fuisz Technologies Ltd.	Method of making crystalline sugar and products resulting therefrom
US5935600A (en) *	1993-09-10	1999-08-10	Fuisz Technologies Ltd.	Process for forming chewable quickly dispersing comestible unit and product therefrom
US5433951A (en) *	1993-10-13	1995-07-18	Bristol-Myers Squibb Company	Sustained release formulation containing captopril and method
AT401871B (de) *	1994-01-28	1996-12-27	Gebro Broschek Gmbh	Verfahren zur herstellung von s(+)-ibuprofen- partikeln mit verbesserten fliesseigenschaften und deren verwendung zur arzneimittelherstellung
DE69535127T2 (de) *	1994-03-18	2007-02-15	Supernus Pharmaceuticals, Inc.	Emulgierte arzneistoffabgabesysteme
US5605889A (en) *	1994-04-29	1997-02-25	Pfizer Inc.	Method of administering azithromycin
DE69524214T3 (de) *	1994-05-06	2008-05-15	Pfizer Inc.	Azithromycin enthaltende arzneiverabreichungsformen mit gesteuerter wirkstoffabgabe
DE19509807A1 (de) *	1995-03-21	1996-09-26	Basf Ag	Verfahren zur Herstellung von Wirkstoffzubereitungen in Form einer festen Lösung des Wirkstoffs in einer Polymermatrix sowie mit diesem Verfahren hergestellte Wirkstoffzubereitungen
US5567439A (en) *	1994-06-14	1996-10-22	Fuisz Technologies Ltd.	Delivery of controlled-release systems(s)
US5582855A (en) *	1994-07-01	1996-12-10	Fuisz Technologies Ltd.	Flash flow formed solloid delivery systems
US5556652A (en) *	1994-08-05	1996-09-17	Fuisz Technologies Ltd.	Comestibles containing stabilized highly odorous flavor component delivery systems
US5601761A (en) *	1994-09-26	1997-02-11	The Dow Chemical Company	Encapsulated active materials and method for preparing same
US5965164A (en) *	1994-10-28	1999-10-12	Fuisz Technologies Ltd.	Recipient-dosage delivery system
US5683720A (en) *	1994-10-28	1997-11-04	Fuisz Technologies Ltd.	Liquiflash particles and method of making same
US5965161A (en) *	1994-11-04	1999-10-12	Euro-Celtique, S.A.	Extruded multi-particulates
FR2732621B1 (fr) *	1995-04-10	1997-06-06	Rhone Poulenc Chimie	Perles d'un produit presentant le phenomene de surfusion et leur procede d'obtention
CA2219991C (en) *	1995-05-02	2007-10-30	Taisho Pharmaceutical Co., Ltd.	Taste masking pharmaceutical composition for oral administration
US5883103A (en) *	1995-06-07	1999-03-16	Shire Laboratories Inc.	Oral acyclovir delivery
US5747058A (en) *	1995-06-07	1998-05-05	Southern Biosystems, Inc.	High viscosity liquid controlled delivery system
AU6403196A (en) *	1995-06-30	1997-02-05	Baylor University	Polyester/carboxylic acid composite materials
EP0784933A3 (en) *	1995-10-16	1997-11-26	Leaf, Inc.	Extended release of additives in comestible products
US5919489A (en) *	1995-11-01	1999-07-06	Abbott Laboratories	Process for aqueous granulation of clarithromycin
US5705190A (en) *	1995-12-19	1998-01-06	Abbott Laboratories	Controlled release formulation for poorly soluble basic drugs
DE19629753A1 (de) *	1996-07-23	1998-01-29	Basf Ag	Verfahren zur Herstellung von festen Arzneiformen
US6139872A (en) *	1996-08-14	2000-10-31	Henkel Corporation	Method of producing a vitamin product
HRP970485A2 (en) *	1996-09-13	1998-08-31	Joerg Rosenberg	Process for producing solid pharmaceutical forms
US5948407A (en) *	1997-03-19	1999-09-07	Shire Laboratories Inc.	Oral induction of tolerance to parenterally administered non-autologous polypeptides
US6551616B1 (en) *	1997-04-11	2003-04-22	Abbott Laboratories	Extended release formulations of erythromycin derivatives
US6010718A (en) *	1997-04-11	2000-01-04	Abbott Laboratories	Extended release formulations of erythromycin derivatives
DE19729487A1 (de) *	1997-07-10	1999-01-14	Dresden Arzneimittel	Verfahren zur Herstellung von Wirkstoff-Zubereitungen mit kontrollierter Freisetzung aus einer Matrix
SI9700186B (sl) *	1997-07-14	2006-10-31	Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D.	Nova farmacevtska oblika z nadzorovanim sproscanjem zdravilnih ucinkovin
US5869098A (en) *	1997-08-20	1999-02-09	Fuisz Technologies Ltd.	Fast-dissolving comestible units formed under high-speed/high-pressure conditions
EP1028712B1 (en) *	1997-09-19	2005-01-12	Shire Laboratories Inc.	Solid solution beadlet
US6013280A (en) *	1997-10-07	2000-01-11	Fuisz Technologies Ltd.	Immediate release dosage forms containing microspheres
IE970731A1 (en) *	1997-10-07	2000-10-04	Fuisz Internat Ltd	Product and method for the treatment of hyperlipidemia
US6096340A (en) *	1997-11-14	2000-08-01	Andrx Pharmaceuticals, Inc.	Omeprazole formulation
US5891845A (en) *	1997-11-21	1999-04-06	Fuisz Technologies Ltd.	Drug delivery systems utilizing liquid crystal structures
ATE500815T1 (de) *	1997-12-08	2011-03-15	Dietrich Rango	Neue suppositoriumsform mit säureempfindlichem wirkstoff
US6270804B1 (en) *	1998-04-03	2001-08-07	Biovail Technologies Ltd.	Sachet formulations
US6117452A (en) *	1998-08-12	2000-09-12	Fuisz Technologies Ltd.	Fatty ester combinations
US6086920A (en) *	1998-08-12	2000-07-11	Fuisz Technologies Ltd.	Disintegratable microspheres
US6248363B1 (en) *	1999-11-23	2001-06-19	Lipocine, Inc.	Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6395300B1 (en) *	1999-05-27	2002-05-28	Acusphere, Inc.	Porous drug matrices and methods of manufacture thereof
US20030180352A1 (en) *	1999-11-23	2003-09-25	Patel Mahesh V.	Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
CA2396426A1 (en) *	2000-01-04	2001-07-12	Teva Pharmaceutical Industries Ltd.	Preparation method of azithromycin dihydrate
IT1320176B1 (it) *	2000-12-22	2003-11-26	Nicox Sa	Dispersioni solide di principi attivi nitrati.
EP1368006B1 (en) *	2001-02-13	2006-05-03	AstraZeneca AB	Novel modified released formulation
DE60320940D1 (de) *	2002-02-01	2008-06-26	Pfizer Prod Inc	Pharmazeutische zusammensetzungen amorpher dispersionen von wirkstoffen und lipophiler mikrophasenbildender materialien
US6682759B2 (en) *	2002-02-01	2004-01-27	Depomed, Inc.	Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs
AR038375A1 (es) *	2002-02-01	2005-01-12	Pfizer Prod Inc	Composiciones farmaceuticas de inhibidores de la proteina de transferencia de esteres de colesterilo

2004
- 2004-11-22 BR BRPI0416535-7A patent/BRPI0416535A/pt not_active IP Right Cessation
- 2004-11-22 KR KR1020087015425A patent/KR20080064209A/ko not_active Withdrawn
- 2004-11-22 KR KR1020067011027A patent/KR20060109481A/ko not_active Ceased
- 2004-11-22 AU AU2004294813A patent/AU2004294813A1/en not_active Abandoned
- 2004-11-22 CN CNA2004800358177A patent/CN1889931A/zh active Pending
- 2004-11-22 EP EP04798952A patent/EP1701702A1/en not_active Withdrawn
- 2004-11-22 RU RU2006119464/15A patent/RU2006119464A/ru unknown
- 2004-11-22 JP JP2006542040A patent/JP2007513143A/ja not_active Abandoned
- 2004-11-22 WO PCT/IB2004/003839 patent/WO2005053653A1/en not_active Ceased
- 2004-11-22 CA CA002547773A patent/CA2547773A1/en not_active Abandoned
- 2004-12-01 TW TW093137051A patent/TW200528138A/zh unknown
- 2004-12-03 AR ARP040104514A patent/AR046468A1/es unknown
- 2004-12-03 US US11/003,856 patent/US20050158391A1/en not_active Abandoned
2006
- 2006-05-18 IL IL175745A patent/IL175745A0/en unknown
- 2006-05-24 NO NO20062389A patent/NO20062389L/no not_active Application Discontinuation
- 2006-06-01 ZA ZA200604495A patent/ZA200604495B/en unknown

Also Published As

Publication number	Publication date
BRPI0416535A (pt)	2007-01-09
TW200528138A (en)	2005-09-01
IL175745A0 (en)	2006-09-05
CA2547773A1 (en)	2005-06-16
WO2005053653A1 (en)	2005-06-16
JP2007513143A (ja)	2007-05-24
AR046468A1 (es)	2005-12-07
ZA200604495B (en)	2008-03-26
RU2006119464A (ru)	2007-12-20
CN1889931A (zh)	2007-01-03
AU2004294813A1 (en)	2005-06-16
KR20080064209A (ko)	2008-07-08
KR20060109481A (ko)	2006-10-20
US20050158391A1 (en)	2005-07-21
EP1701702A1 (en)	2006-09-20

Legal Events

Date	Code	Title	Description
2010-06-28	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
ATE425136T1 (de)	2009-03-15	Verfahren zur herstellung substituierter 3-aryl- butyl-aminverbindungen
EA200800886A1 (ru)	2008-08-29	Способ получения 1-н-имидазо[4,5-с]пиридинов и их аналогов
DK1467993T3 (da)	2008-11-10	Fremgangsmåde til fremstilling af scopinestere
EA200600621A1 (ru)	2006-10-27	Производные тетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств
TWI371438B (en)	2012-09-01	Process for producing an organic compound
ATE414077T1 (de)	2008-11-15	Verfahren zur herstellung von 1-ä(benzimidazol-1- yl)chinolin-8-ylüpiperidin-4-ylaminderivaten
ATE435231T1 (de)	2009-07-15	Verfahren zur herstellung verzweigterribonukleoside aus 1,2- anhydroribofuranose-zwischenprodukten
FI20030241L (fi)	2004-08-18	Menetelmä synteesikaasun tuottamiseksi
DE50307242D1 (de)	2007-06-21	Verfahren zum herstellen von einkristallinen strukturen
ATE332304T1 (de)	2006-07-15	Cefdinir salze als zwischenprodukte
ATE354583T1 (de)	2007-03-15	Verfahren zur herstellung c-7 substituierter 5- androstene
DE602004020916D1 (de)	2009-06-10	Verfahren zum Herstellen von hochreinem Hafnium
ATE431339T1 (de)	2009-05-15	Verfahren zur herstellung von n-amino- substituierten heterocyclischen verbindungen
DE602004030091D1 (de)	2010-12-30	Verfahren zur reduktiven deshalogenierung
EP1539703A4 (en)	2007-02-21	METHOD FOR SELECTIVELY PREPARING A 3-OXO-4-AZA-5A ANDROSTAN COMPOUND
ATE514702T1 (de)	2011-07-15	Verfahren zur herstellung von clopidogrel und dabei verwendete zwischenprodukte
DE602004014822D1 (de)	2008-08-14	Neues verfahren zur herstellung von nitrooxyderivaten von paracetamol
AR046468A1 (es)	2005-12-07	Formas de dosificacion multiparticuladas de azitromicina mejoradas obtenidas mediante procedimientos de coagulacion en estado fundido
ATE541838T1 (de)	2012-02-15	Neue zur synthese von s- und r-omeprazol geeignete verbindungen und ein verfahren zu deren herstellung
CY1112457T1 (el)	2015-12-09	Χρωμανο- και θειοxρωμανο-3-υλο-1,3-διυδρο-ιμιδαζολια ως αναστολεις της ντοπαμινο-β-υδροξυλασης, και μεθοδοι παρασκευης αυτων
ATE370950T1 (de)	2007-09-15	Verfahren zur herstellung von (1s,4r)-cis-4-(2- amino-6-chlor-9h-purin-9-yl)-2-cyclopenten-1- methanol
ATE549315T1 (de)	2012-03-15	Verfahren zur herstellung von kristallinem perindopril
ATE423775T1 (de)	2009-03-15	Verfahren zur herstellung von lactonen
DK1656340T3 (da)	2012-10-01	Fremgangsmåde til fremstilling af 1-carbamoylcykloalkylcarboxylsyreforbindelser
ATE517890T1 (de)	2011-08-15	Verfahren zur herstellung von reinem irbesartan